An interesting study was recently published about a now-forgotten vaccination against a once-fashionable virus:
The study was conducted on a huge sample of people and showed significant harm, which I wrote/talked about back in 2021.
Let's look at the study's findings together, and then watch my little slideshow of the "experts" (thinking geniuses 
) from Instagram/clinics/organizations who called me and other reasonable people names during those "dark" times...
Unfortunately, they all continue their stupid actions in the field of public health. 
Theses from the study itself:
The Global COVID Vaccine Safety (GCoVS) project, established in 2021 as part of the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive vaccine safety assessments. This study aimed to assess the risk of adverse events of particular concern (AESIs) following COVID-19 vaccination at 10 sites in eight countries.
Methods
Using a common protocol, this observational cohort study compared observed and expected rates of 13 selected AESIs across neurological, hematological, and cardiac outcomes. Expected rates were generated by participating institutions using pre-COVID-19 vaccination medical records stratified by age and sex. Observed rates were generated from the same medical datasets used since the COVID-19 vaccination program was rolled out. The primary analysis included AESIs occurring within 42 days of vaccination with mRNA (BNT162b2 and mRNA-1273) and adenovirus-vectored vaccines (ChAdOx1). Risks were assessed using observed-to-expected (OE) ratios with 95% confidence intervals. Priority potential safety signals were those with a lower bound of the 95% confidence interval (LBCI) greater than 1.5.
Results obtained
A total of 99,068,901 vaccinated individuals were included. A total of 183,559,462 doses of BNT162b2, 36,178,442 doses of mRNA-1273, and 23,093,399 doses of ChAdOx1 were administered at participating centers during the study period. The periods of risk after homologous vaccination regimens amounted to 23,168,335 person-years of observation. OE ratios with LBCI > 1.5 were observed for Guillain-Barré syndrome (2.49, 95% CI: 2.15, 2.87) and cerebral venous sinus thrombosis (3.23, 95% CI: 2.51, 4.09) after the first dose of ChAdOx1 vaccine. For acute disseminated encephalomyelitis, the OE ratio was 3.78 (95% CI: 1.52, 7.78) after the first dose of mRNA-1273 vaccine. The OE ratios for myocarditis and pericarditis after BNT162b2, mRNA-1273, and ChAdOx1 were significantly increased at LBCI > 1.5.
Conclusion
This multi-country analysis confirmed previously identified safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals were also identified that require further investigation.
Now let's take a look together at what the "experts" once wrote:
The link to the study is here: https://www.sciencedirect.com/science/article/pii/S0264410X24001270?via%3Dihub
